1. Andersson, Kristin B, Winer, Lisbeth H, Mørk, Halvor K, Molkentin, Jeffery D, Jaisser, Frédéric. 2009. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts. In Transgenic research, 19, 715-25. doi:10.1007/s11248-009-9342-4. https://pubmed.ncbi.nlm.nih.gov/19894134/
2. Ren, Yun-Qing, Gao, Min, Liang, Yan-Hua, Yang, Sen, Zhang, Xue-Jun. 2006. Five mutations of ATP2A2 gene in Chinese patients with Darier's disease and a literature review of 86 cases reported in China. In Archives of dermatological research, 298, 58-63. doi:. https://pubmed.ncbi.nlm.nih.gov/16552539/
3. Broman, Michael T, Nadadur, Rangarajan D, Perez-Cervantes, Carlos, Svensson, Eric C, Moskowitz, Ivan P. 2024. A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network. In Circulation, 149, 1205-1230. doi:10.1161/CIRCULATIONAHA.123.066804. https://pubmed.ncbi.nlm.nih.gov/38189150/
4. Korosec, Branka, Glavac, Damjan, Rott, Tomaz, Ravnik-Glavac, Metka. . Alterations in the ATP2A2 gene in correlation with colon and lung cancer. In Cancer genetics and cytogenetics, 171, 105-11. doi:. https://pubmed.ncbi.nlm.nih.gov/17116488/
5. Atzmony, Lihi, Zagairy, Fadia, Mawassi, Banan, Dodiuk-Gad, Roni, Cohen-Barak, Eran. . Persistent Cutaneous Lesions of Darier Disease and Second-Hit Somatic Variants in ATP2A2 Gene. In JAMA dermatology, 160, 518-524. doi:10.1001/jamadermatol.2024.0152. https://pubmed.ncbi.nlm.nih.gov/38536168/